MGMT promoter hypermethylation has also been associated with poorer outcomes for oral cancer, including a greater likelihood of nodal metastases, tumor recurrence, and decreased survival [32, 33]. This evidence concerns the gene MGMT and lip and oral cavity carcinoma.